Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases
AssigneeBiosite, Inc.
InventorsKenneth F. Buechler, Alan Maisel
Life of this patent
Estimating the term…
Loading patent…
AssigneeBiosite, Inc.
InventorsKenneth F. Buechler, Alan Maisel
Estimating the term…
The present invention relates to methods for the diagnosis and evaluation of acute coronary syndromes. In particular, patient test samples are analyzed for the presence and amount of members of a panel of markers comprising one or more specific markers for myocardial injury and one or more non-specific markers for myocardial injury. A variety of markers are disclosed for assembling a panel of markers for such diagnosis and evaluation. In various aspects, the invention provides methods for the early detection and differentiation of stable angina, unstable angina, and myocardial infarction. Invention methods provide rapid, sensitive and specific assays that can greatly increase the number of patients that can receive beneficial treatment and therapy, reduce the costs associated with incorrect diagnosis, and provide important information about the prognosis of the patient.
A method of predicting a risk of one or more future clinical outcomes for a subject suffering from a vascular disease, comprising:
A method of diagnosing atherosclerosis in a subject, comprising:
Dependencies are inferred from the claim text.